Effect of levamisole in inhibition of DMBA carcinogenesis.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000037:antagonists & inhibitors*; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000473:pathology; D006965:Hyperplasia / Q000473:pathology; D007978:Levamisole / Q000494:pharmacology*; D008679:Metaplasia / Q000473:pathology; D051381:Rats; D011919:Rats, Inbred Strains; D012468:Salivary Gland Neoplasms / Q000139:chemically induced*; D013363:Submandibular Gland / Q000473:pathology; D013365:Submandibular Gland Neoplasms / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology
D007978:Levamisole; D015127:9,10-Dimethyl-1,2-benzanthracene